Bronkese 169.4mg/50.6mg Injection
By Bronkese
Rx
2ml Injection in a Vial

Composition
Etofylline(169.4mg) + Theophylline(50.6mg)

Manufacturer - Tribhawan Injectables
Plot No-C/11, Sector 4, DSIDC, Industrial complex, Bawana Industrial Area, Narela Zone, Gali No-39, Delhi-110039, India

Expires on or after
September, 2025

liver
Bronkese 169.4mg/50.6mg Injection requires caution when used in patients with liver disease. It may be necessary to adjust the dosage of this medication in such individuals. It is advised to seek guidance from your doctor regarding the use of Bronkese 169.4mg/50.6mg Injection if you have any liver-related concerns.

kidney
Consult your doctor for proper guidance before using Bronkese 169.4mg/50.6mg Injection.

alcohol
It is not recommended to drink alcohol while using Bronkese 169.4mg/50.6mg Injection.

driving
When using Bronkese 169.4mg/50.6mg Injection, avoid driving if you notice any symptoms impacting your focus or reaction time. It’s uncertain how this injection affects driving abilities, so stay cautious.

pregnancy
Bronkese 169.4mg/50.6mg Injection may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor to discuss benefits and risks before use.

breastfeeding
When breastfeeding while using Bronkese 169.4mg/50.6mg Injection, studies show minimal transfer to breastmilk. To reduce exposure, wait 2-4 hours after the injection before nursing.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹3.34
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025